Medical News

RSS

Researchers to find better ways to manage chronic pain by treating neuroinflammation

Thanks to a two year, $974,024 NIH-funded ARRA (American Recovery and Reinvestment Act) grant, Saint Louis University and Southern Illinois University Edwardsville researchers are working to find better ways to manage chronic pain by treating neuroinflammation.

4 Nov 2009

Hastings Hearing Centre's initiative to spread the word concerning the consequences of hearing loss

Brandon's Hastings Hearing Centre is attempting to spread the word concerning the consequences of hearing loss. The clinic hopes to do so by connecting with the community through the sport of hockey.

4 Nov 2009

New FDA-approved heart pump for high-risk patients

Cardiologists at the University of Illinois Medical Center are using a new heart pump that can be inserted without the need for surgery and allows them to treat high-risk patients with a procedure to unblock their heart arteries.

4 Nov 2009

Hydrogen peroxide may act as a signal for the active and resting phases of living things: Study

If a circadian rhythm is like an orchestra - the united expression of the rhythms of millions of cells - a common chemical may serve as the conductor, or at least as the baton.

4 Nov 2009

Kaz launches new energy-savings educational website

Increasingly, many Americans are interested in purchasing products that help them save money while saving energy. In fact, the U.S. government recently earmarked $300 million in federal stimulus money for rebate programs for consumers who buy appliances rated for energy efficiency. But many consumers may not realize they don't have to sacrifice whole home comfort to make smart, economical choices about the air purifiers, heaters and air circulators they purchase.

4 Nov 2009

Non-small cell lung cancer patients who undergo PCI decrease their risk of developing brain metastases

Patients with non-small cell lung cancer treated with preventative brain radiation (called prophylactic cranial irradiation or PCI), significantly decrease their risk of developing brain metastases (cancer spread in the brain) by more than 50 percent (from 18 percent to 8 percent), compared to those who did not receive the treatment, according to a randomized study presented at the plenary session November 2, 2009, at the 51st Annual Meeting of American Society for Radiation Oncology (ASTRO).

4 Nov 2009

ThromboGenics issues business update for the third-quarter of 2009

ThromboGenics NV, a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, is today issuing a business update for the period ending 30 September, 2009.

4 Nov 2009

Scientists develop technique to predict new target diseases for existing drugs

Scientists at the University of North Carolina at Chapel Hill School of Medicine and the University of California, San Francisco have developed and experimentally tested a technique to predict new target diseases for existing drugs.

4 Nov 2009

Study results of nucleoside polymerase and protease inhibitor combination therapy for HCV promising

All approved therapy regimens to treat patients with hepatitis C are based on interferon, which must be injected. In this clinical trial to be presented at the annual meeting of the American Association for the Study of Liver Diseases, researchers treated patients - both treatment naive and experienced patients - with a twice daily oral combination therapy of a nucleoside polymerase and protease inhibitor.

4 Nov 2009

Symposium to address complex issues surrounding water and health

On November 13, the Johns Hopkins Bloomberg School of Public Health and the New York Academy of Sciences will host a symposium to address the complex issues surrounding water and health.

4 Nov 2009

Takeda Pharmaceuticals strengthens its North American market

Takeda Pharmaceuticals North America, Inc., today announced the incorporation of Takeda Pharmaceuticals Mexico, S.A. de C.V. This expansion strengthens the company's North American presence, bolstering existing operations in the United States and Canada. Takeda Pharmaceuticals Mexico will be headquartered in Mexico City.

4 Nov 2009

Higher testosterone levels in older women are associated with increased health risks

Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

4 Nov 2009

Patients who have an undetectable level of PSA after therapy have good chance of being cured

Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients. Patients who have an undetectable level of PSA after therapy have less chance of biochemical failure than other patients and a good chance of being cured.

4 Nov 2009

Hospitalization and death of H1N1 patients can occur at all ages, says study

In contrast with some common perceptions regarding 2009 influenza A(H1N1) infections, an examination of cases in California indicates that hospitalization and death can occur at all ages, and about 30 percent of hospitalized cases have been severe enough to require treatment in an intensive care unit, according to a study in the November 4 issue of JAMA.

4 Nov 2009

Oberthur Technologies and Groupe Sephira collaborate to deliver electronic billing solution for French healthcare industry

Oberthur Technologies, the world's second largest provider of Smart Card based solutions, and Groupe Sephira, leading supplier of electronic claims for the French Healthcare Committee, jointly announce their attendance at the Salon CARTES et Identification which will take place in Paris, November 17-19, 2009.

4 Nov 2009

NanoLogix files international patent applications for its BioNanoPore microorganism detecting technology

NanoLogix, Inc. announces that the company has recently filed BNP™ (BioNanoPore) national patent applications in China, Japan, India, Brazil, Russia and the EU. These applications were filed in order to obtain intellectual property protection for the company's technology in countries viewed as representing the largest potential international market for BNP rapid detection, a revolutionary sandwiched-membrane Petri-based technology that can reduce microorganism detection times by 100-400%.

4 Nov 2009

iPhone application for analyzing sleep apnea developed

Remote Analysis Ltd, a telemedicine services provider, has in cooperation with Elias Pietilä’s Qvik Ltd (Wooden Labyrinth, for example) developed an iPhone application for recording and analyzing snoring and sleep apnea. The Sleep Aid –application is now available on the iPhone App Store for € 2,39.

4 Nov 2009

Survey shows majority of rheumatologists would prescribe Actemra drug for rheumatoid arthritis

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 98 percent of surveyed rheumatologists indicate they will prescribe Roche's Actemra, an interleukin-6 inhibitor, for the treatment of rheumatoid arthritis following the agent's expected launch in 2010.

4 Nov 2009

Eating a meal quickly curtails the release of hormones in the gut and can lead to overeating

According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), eating a meal quickly, as compared to slowly, curtails the release of hormones in the gut that induce feelings of being full. The decreased release of these hormones, can often lead to overeating.

4 Nov 2009

Phase Forward and PharmaNet Development Group sign multi-year agreement

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with PharmaNet Development Group, Inc., a global drug development services company, that enables PharmaNet to offer Phase Forward’s InForm™ electronic data capture (EDC) solution to PharmaNet customers worldwide.

4 Nov 2009

Medical News

Researchers to find better ways to manage chronic pain by treating neuroinflammation

Hastings Hearing Centre's initiative to spread the word concerning the consequences of hearing loss

New FDA-approved heart pump for high-risk patients

Hydrogen peroxide may act as a signal for the active and resting phases of living things: Study

Kaz launches new energy-savings educational website

Non-small cell lung cancer patients who undergo PCI decrease their risk of developing brain metastases

ThromboGenics issues business update for the third-quarter of 2009

Scientists develop technique to predict new target diseases for existing drugs

Study results of nucleoside polymerase and protease inhibitor combination therapy for HCV promising

Symposium to address complex issues surrounding water and health

Takeda Pharmaceuticals strengthens its North American market

Higher testosterone levels in older women are associated with increased health risks

Patients who have an undetectable level of PSA after therapy have good chance of being cured

Hospitalization and death of H1N1 patients can occur at all ages, says study

Oberthur Technologies and Groupe Sephira collaborate to deliver electronic billing solution for French healthcare industry

NanoLogix files international patent applications for its BioNanoPore microorganism detecting technology

iPhone application for analyzing sleep apnea developed

Survey shows majority of rheumatologists would prescribe Actemra drug for rheumatoid arthritis

Eating a meal quickly curtails the release of hormones in the gut and can lead to overeating

Phase Forward and PharmaNet Development Group sign multi-year agreement

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News